Mancini Marianna — SEC Form 4 filings
SEC reporting owner CIK 1838112. 9 Form 4 filings on record with FilingPulse; latest filed 2026-07-29.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-03-04 to 2026-07-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 7 filings — 439,995 shares, $28,329,990 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: sale of 119,946 shares @ $79.29 ($9,511,058) in Viking Therapeutics, Inc., filed 2024-05-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | Chief Operating Officer | 9 | — | 16 legs · 439,995 sh · $28,329,990 | 25 |
Form 4 filings — Mancini Marianna
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-29 | 4 | Viking Therapeutics, Inc. (VKTX) | Grant/award (A): 31,667 @ $0 · Sale (S): 18,217 @ $33.47 | EDGAR |
| 2026-01-05 | 4 | Viking Therapeutics, Inc. (VKTX) | Grant/award (A): 41,000 @ $0 · Grant/award (A): 32,049 @ $0 · Sale (S): 31,961 @ $32.29 · Sale (S): 13,600 @ $33.37 · Sale (S): 10,500 @ $34.22 · Sale (S): 1,600 @ $35.07 · +1 more | EDGAR |
| 2025-10-28 | 4 | Viking Therapeutics, Inc. (VKTX) | Grant/award (A): 11,117 @ $0 · Sale (S): 6,185 @ $35.00 | EDGAR |
| 2025-07-03 | 4 | Viking Therapeutics, Inc. (VKTX) | Grant/award (A): 7,667 @ $0 · Sale (S): 4,266 @ $27.77 | EDGAR |
| 2025-01-06 | 4 | Viking Therapeutics, Inc. (VKTX) | Grant/award (A): 44,533 @ $0 · Grant/award (A): 21,667 @ $0 · Sale (S): 49,115 @ $42.69 · Sale (S): 5,100 @ $43.32 · Grant/award (A): 37,200 (derivative) @ $0 | EDGAR |
| 2024-07-31 | 4 | Viking Therapeutics, Inc. (VKTX) | Grant/award (A): 10,000 @ $0 · Grant/award (A): 21,667 @ $0 · Sale (S): 14,704 @ $56.98 · Sale (S): 3,322 @ $57.82 | EDGAR |
| 2024-05-02 | 4 | Viking Therapeutics, Inc. (VKTX) | Option exercise (M): 17,999 @ $4.68 · Option exercise (M): 87,000 @ $4.88 · Option exercise (M): 90,000 @ $5.80 · Option exercise (M): 35,426 @ $7.77 · Option exercise (M): 51,000 @ $8.52 · Sale (S): 23,746 @ $76.40 · +9 more | EDGAR |
| 2024-03-27 | 4 | Viking Therapeutics, Inc. (VKTX) | Grant/award (A): 31,667 @ $0 · Tax withholding (F): 16,610 @ $83.34 | EDGAR |
| 2024-03-04 | 4 | Viking Therapeutics, Inc. (VKTX) | Grant/award (A): 31,667 @ $0 · Tax withholding (F): 16,958 @ $85.22 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1838112 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →